Can You Get Mounjaro With a BMI of 27?

A BMI of 27 falls within the licensed range for Mounjaro, provided at least one weight-related condition is present.
Qualifying conditions include type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnoea, and cardiovascular disease, among others.
For some South Asian, Chinese, Middle Eastern, Black African, and African-Caribbean backgrounds, UK guidance applies BMI thresholds 2.5 kg/m² lower, so a BMI of 27 may sit even more comfortably within range.
Clinical suitability is determined by a prescriber, not by BMI alone; other health factors and contraindications are always considered.

Yes, a BMI of 27 can qualify you for Mounjaro (tirzepatide), but only if you also have at least one weight-related health condition. The medicine's UK licence covers adults with a BMI of 27 or above alongside a qualifying comorbidity such as type 2 diabetes, high blood pressure, or high cholesterol. BMI alone is not enough, and a prescriber makes the final decision after a full clinical assessment. These are prescription-only medicines, so a genuine consultation — reviewing your full health picture — is required before any treatment can be issued.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the licence and UK guidance actually say about BMI 27 and Mounjaro

Does the Mounjaro licence really cover a BMI of 27?

It does. Tirzepatide's UK marketing authorisation permits prescribing for adults with a BMI of 30 or above, or a BMI of 27 or above when at least one weight-related comorbidity is present. That second threshold is the relevant one here. The NHS tirzepatide medicines page sets out the licensed indications clearly, and the prescribing information confirms both BMI bands.

What counts as a qualifying comorbidity? The list includes type 2 diabetes, prediabetes, high blood pressure, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea, and osteoarthritis, among others. If you have a formal diagnosis of any of these, a BMI of 27 puts you inside the licensed criteria for Mounjaro on paper. That said, paper criteria are the starting point, not the finish line. A prescriber will still assess your wider health, any contraindications, and whether treatment is appropriate for you specifically.

It is also worth knowing that UK guidance acknowledges different average body compositions across ethnic groups. For people from South Asian, Chinese, Middle Eastern, Black African, or African-Caribbean backgrounds, clinical thresholds are often set 2.5 kg/m² lower, meaning the bar is easier to meet at a BMI of 27. The full breakdown of BMI requirements for Mounjaro covers these nuances in more detail.

What if I have a BMI of 27 but no diagnosed condition?

This is the scenario where the answer shifts. Without a weight-related comorbidity on record, a BMI of 27 does not currently meet the UK licensed threshold for tirzepatide. The licence is unambiguous on this point: the lower BMI band only applies alongside a qualifying diagnosis. A prescriber cannot legitimately issue a Mounjaro prescription for weight management alone at BMI 27, and any service offering to do so without satisfying this requirement would be acting outside the licensed indications.

If you are unsure whether a condition you have qualifies, that is exactly the kind of question a structured consultation is designed to answer. Conditions are sometimes diagnosed during the assessment process itself, particularly blood pressure and cholesterol readings that a person was not previously aware of. Our general FAQs address some of the more common eligibility questions if you want to read further before booking.

People with a BMI slightly above or below 27 sometimes ask about adjacent thresholds, there is a separate look at the evidence for whether Mounjaro is available at BMI 25 if that is closer to your situation.

How does the NHS differ from private prescribing at BMI 27?

The NHS criteria for tirzepatide are considerably stricter than the private licensed criteria. NICE's appraisal of tirzepatide (TA1026, published December 2024) recommends it on the NHS for adults with a BMI of 35 or above alongside at least one qualifying condition, within a phased rollout through specialist services. At BMI 27, NHS access is not available under current guidance.

Private prescribing follows the medicine's licensed criteria directly, which is why a BMI of 28 with a comorbidity, or indeed 27, can be clinically appropriate through a regulated private pharmacy. There is no waiting list, no referral needed, and no requirement to meet the higher NHS thresholds. The consultation happens the same day; a named prescriber reads your answers and medical history personally, not software. If you are approved, your treatment is dispatched the same working day (orders placed by 12pm Monday to Friday) and arrives free the next working day via DPD in plain packaging.

For context on what private treatment costs at different stages, the Mounjaro cost page explains what goes into private pricing and what a transparent single price should include. Worth reading before comparing providers.

What happens during the consultation if my BMI is 27?

At BMI 27, the consultation tends to focus particularly on confirming the comorbidity that brings you into licensed range. You will be asked about your medical history, current diagnoses, any medicines you take, and relevant lifestyle factors. Live weight verification means our prescribers can confirm your BMI rather than relying on a self-reported figure, an important step when the threshold matters as much as it does here.

If you are on other medicines, your prescriber will check for any interactions or considerations. For example, people asking whether they can get Mounjaro at a BMI of 27 sometimes also want to know about combining it with certain blood pressure medicines; our prescribers can discuss that specifically during assessment. Identity is verified with photo ID as a standard step, and a GP notification is sent in line with GPhC guidance so your wider care team is informed.

Our clinical team brings specialist prescribing experience to every review. No consultation is a box-ticking exercise, if treatment is not right for you, that will be explained clearly, with guidance on what the appropriate next step looks like. If you would like to understand the process before starting, the treatment overview page gives a plain-English summary of what to expect.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions